Life SciencesGeneticsMolecular GeneticsMolecular NeuroscienceNeurodegenerationNeurogeneticsHuntington DiseaseMolecular Basis Of NeurodegenerationMolecular NeurogeneticsNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersHuntingtin AggregationHuntingtin ProteinLoss Of Protein FunctionLoss-of-function EffectsLoss-of-function VariantsPleiotropic EffectsPolyglutamine DiseasesPolyglutamine Expansion Disorders
Huntington's Disease is an adult-onset dominant heritable disorder characterized by progressive psychiatric disruption, cognitive deficits, and loss of motor coordination. It is caused by expansion of a polyglutamine tract within the N-terminal domain of the Huntingtin protein. The mutation confers a toxic gain-of-function phenotype, resulting in neurodegeneration that is most severe in the striatum. Increasing experimental evidence from genetic model systems such as mice, zebrafish, and Drosophila suggest that polyglutamine expansion within the Huntingtin protein also disrupts its normal biological function. Huntingtin is widely expressed during development and has a complex and dynamic distribution within cells. It is predicted to be a protein of pleiotropic function, interacting with a large number of effector proteins to mediate a host of physiological processes. In this review, we highlight the wildtype function of Huntingtin, focusing on its postdevelopmental roles in axonal trafficking, regulation of gene transcription, and cell survival. We then discuss how potential loss-of-function phenotypes resulting in polyglutamine expansion within Huntingtin may have direct relevance to the underlying pathophysiology of Huntington's Disease.
148
Impairment of the Ubiquitin-Proteasome System by Protein Aggregation
Neil Bence, Roopal M. Sampat, Ron R. Kopito · Science · 2001 · 2.2K citations
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
Joan S. Steffan, László Bodai, Judit Pallos et al. · Nature · 2001 · 1.2K citations · Full text